Tsuruha Holdings Inc. (TYO:3391)
11,275
+70 (0.62%)
Jun 27, 2025, 3:30 PM JST
Tsuruha Holdings Revenue
In the fiscal year ending February 28, 2025, Tsuruha Holdings had annual revenue of 1.01T JPY, down -1.24%. Tsuruha Holdings had revenue of 309.27B in the quarter ending February 28, 2025, with 19.69% growth.
Revenue (ttm)
1,098.95B
Revenue Growth
+6.96%
P/S Ratio
0.54
Revenue / Employee
89.81M
Employees
11,298
Market Cap
550.78B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Feb 28, 2025 | 1,014.72B | -12.74B | -1.24% |
May 15, 2024 | 1,027.46B | 57.38B | 5.92% |
May 15, 2023 | 970.08B | 54.38B | 5.94% |
May 15, 2022 | 915.70B | -3.60B | -0.39% |
May 15, 2021 | 919.30B | 78.27B | 9.31% |
May 15, 2020 | Pro | Pro | Pro |
May 15, 2019 | Pro | Pro | Pro |
May 15, 2018 | Pro | Pro | Pro |
May 15, 2017 | Pro | Pro | Pro |
May 15, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,222.12B |
Takeda Pharmaceutical Company | 4,581.55B |
Daiichi Sankyo Company | 1,886.26B |
HOYA Corporation | 866.03B |
Terumo | 1,036.17B |
Otsuka Holdings | 2,393.18B |
Astellas Pharma | 1,912.32B |
Shionogi & | 438.27B |